Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Binka

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Malaria Journal|March 20, 2021
Correction to: Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malariaThomas A Anyorigiya, Sandra Castel, Katya Mauf, et al.
Lancet (London, England)|December 14, 2002
An open letter to the Executive Board of WHOFred Binka, Richard Cash, Lincoln Chen, et al.
Plos Medicine|February 12, 2011
A research agenda to underpin malaria eradicationPedro L Alonso, Graham Brown, Myriam Arevalo-Herrera, et al.
Malaria Journal|April 18, 2015
Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and TanzaniaRita Baiden, Abraham Oduro, Tinto Halidou, et al.
The Pan African Medical Journal|September 22, 2021
Epidemiology of intussusception in infants less than one year of age in Ghana, 2012-2016Hope Glover-Addy, Daniel Ansong, Christabel Enweronu-Laryea, et al.
Malaria Journal|January 29, 2016
Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim(®)) in the treatment of uncomplicated malaria at public health facilities in four African countriesAlexander Adjei, Solomon Narh-Bana, Alberta Amu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
Pre-referral Rectal Artesunate Treatment by Community-Based Treatment Providers in Ghana, Guinea-Bissau, Tanzania, and Uganda (Study 18): A Cluster-Randomized TrialMarian Warsame, Margaret Gyapong, Betty Mpeka, et al.
Bulletin of the World Health Organization|September 5, 2007
Setting international standards for verbal autopsyFrank Baiden, Ayaga Bawah, Sidu Biai, et al.
Plos One|October 21, 2016
Multi-Country Evaluation of Safety of Dihydroartemisinin/Piperaquine Post-Licensure in African Public Hospitals with ElectrocardiogramsAbdunoor M Kabanywanyi, Rita Baiden, Ali M Ali, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2020
Pooled Multicenter Analysis of Cardiovascular Safety and Population Pharmacokinetic Properties of Piperaquine in African Patients with Uncomplicated Falciparum MalariaThanaporn Wattanakul, Bernhards Ogutu, Abdunoor M Kabanywanyi, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Malaria Journal|March 20, 2021
Correction to: Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malariaThomas A Anyorigiya, Sandra Castel, Katya Mauf, et al.
Lancet (London, England)|December 14, 2002
An open letter to the Executive Board of WHOFred Binka, Richard Cash, Lincoln Chen, et al.
Plos Medicine|February 12, 2011
A research agenda to underpin malaria eradicationPedro L Alonso, Graham Brown, Myriam Arevalo-Herrera, et al.
Malaria Journal|April 18, 2015
Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and TanzaniaRita Baiden, Abraham Oduro, Tinto Halidou, et al.
The Pan African Medical Journal|September 22, 2021
Epidemiology of intussusception in infants less than one year of age in Ghana, 2012-2016Hope Glover-Addy, Daniel Ansong, Christabel Enweronu-Laryea, et al.
Malaria Journal|January 29, 2016
Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim(®)) in the treatment of uncomplicated malaria at public health facilities in four African countriesAlexander Adjei, Solomon Narh-Bana, Alberta Amu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
Pre-referral Rectal Artesunate Treatment by Community-Based Treatment Providers in Ghana, Guinea-Bissau, Tanzania, and Uganda (Study 18): A Cluster-Randomized TrialMarian Warsame, Margaret Gyapong, Betty Mpeka, et al.
Bulletin of the World Health Organization|September 5, 2007
Setting international standards for verbal autopsyFrank Baiden, Ayaga Bawah, Sidu Biai, et al.
Plos One|October 21, 2016
Multi-Country Evaluation of Safety of Dihydroartemisinin/Piperaquine Post-Licensure in African Public Hospitals with ElectrocardiogramsAbdunoor M Kabanywanyi, Rita Baiden, Ali M Ali, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2020
Pooled Multicenter Analysis of Cardiovascular Safety and Population Pharmacokinetic Properties of Piperaquine in African Patients with Uncomplicated Falciparum MalariaThanaporn Wattanakul, Bernhards Ogutu, Abdunoor M Kabanywanyi, et al.
Pageof 7